Characterization of variant diphtheria toxin-interleukin-3 fusion protein, DTIL3K116W, for phase I clinical trials. [electronic resource]
Producer: 20100621Description: 144-9 p. digitalISSN:- 1095-8320
- Amino Acid Substitution
- Bone Marrow Cells -- drug effects
- Cells, Cultured
- Clinical Trials, Phase I as Topic -- methods
- Diphtheria Toxin -- adverse effects
- Drug Compounding -- methods
- Drug Contamination -- prevention & control
- Drug Evaluation, Preclinical
- Drug Stability
- Genetic Variation -- physiology
- Humans
- Interleukin-3 -- adverse effects
- Leukemia, Myeloid, Acute -- drug therapy
- Lysine -- genetics
- Recombinant Fusion Proteins -- adverse effects
- Sterilization
- Toxicity Tests
- Tryptophan -- genetics
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.